title: Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.
authors.affiliation: Department of Surgery, Pathology, Immunohematology, National Cancer Institute, Milan, Italy.
authors.forename: V
authors.initials: V
authors.lastname: Mazzaferro
authors.forename: E
authors.initials: E
authors.lastname: Regalia
authors.forename: A
authors.initials: A
authors.lastname: Pulvirenti
authors.forename: A
authors.initials: A
authors.lastname: Tagger
authors.forename: S
authors.initials: S
authors.lastname: Andreola
authors.forename: M
authors.initials: M
authors.lastname: Pasquali
authors.forename: D
authors.initials: D
authors.lastname: Baratti
authors.forename: F
authors.initials: F
authors.lastname: Romano
authors.forename: U
authors.initials: U
authors.lastname: Palazzo
authors.forename: M
authors.initials: M
authors.lastname: Zuin
authors.forename: F
authors.initials: F
authors.lastname: Bonino
authors.forename: M L
authors.initials: ML
authors.lastname: Ribero
authors.forename: L
authors.initials: L
authors.lastname: Gennari
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000401:mortality / Q000517:prevention & control* / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use*; D015996:Survival Rate; D013997:Time Factors
chemical_list: D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D012254:Ribavirin